Our previous studies demonstrated that better glucose control with voglibose, an alpha-glycosidase inhibitor, or vildagliptin, a dipeptidyl-peptidase IV inhibitor, improves heart failure in mice with TAC [3, 25]. Here, DPP4 is linked to persistent truncus arteriosus.